CAPTRUST Financial Advisors
ORGO icon

CAPTRUST Financial Advisors’s Organogenesis Holdings ORGO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,574
Closed -$45.7K – 2577
2025
Q1 		$45.7K Sell
10,574
-1,096
-9% -$4.42K ﹤0.01% 2288
2024
Q4 		$37.3K Sell
11,670
-939
-7% -$3.15K ﹤0.01% 2253
2024
Q3 		$36.1K Buy
+12,609
New +$35.4K ﹤0.01% 2247
2022
Q2 		– Sell
-2,220
Closed -$17K – 5078
2022
Q1 		$17K Buy
+2,220
New +$17.2K ﹤0.01% 3495

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors's ORGO Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 10,574 shares — an estimated $45.7K sold.

CAPTRUST Financial Advisors first reported a position in ORGO in Q1 2022 and held it in 4 quarters. The position peaked at $45.7K in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,574 Organogenesis Holdings shares in Q2 2025, an estimated $45.7K.
  • CAPTRUST Financial Advisors first reported a position in Organogenesis Holdings in Q1 2022 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Organogenesis Holdings position peaked at $45.7K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.